Healthlynked Stock Price, News & Analysis

HealthLynked Corp. (OTCQB: HLYK) has appointed Anthony 'Tony' Scuilla as a strategic sales consultant to focus on securing partnerships with large insurance providers. Scuilla brings over 35 years of executive experience in healthcare information technology sales, having held key positions at AGS Healthcare Group, Alteer Corp., Eclipsys Corp., and Shared Medical Systems.

Throughout his career, Scuilla has launched products generating over $100 million in sales and successfully raised more than $20 million in venture capital. He has extensive experience in building national sales teams and advising healthcare companies on scaling strategies. Currently, he volunteers as a Patient Advocate at Gulf Coast Medical Center and mentors students at Florida Gulf Coast University Entrepreneurship Program.

HealthLynked (OTCQB: HLYK) has announced significant upgrades to its in-office appointment booking platform and ARi voice assistant. The enhanced booking system now offers patients more flexibility with features including next available time slot selection, specific day requests, and morning/afternoon preferences. Patients can also submit provider reviews without logging in, though these will appear as 'unverified'.

The ARi (Artificial Intelligence for Real-Time Interaction) voice assistant improvements focus on reduced background noise interference and prevention of unwanted interruptions through advanced noise-cancellation and detection algorithms. These updates aim to streamline doctor-patient communication and improve the overall healthcare experience for both patients and providers.

HealthLynked Corp. (OTCQB: HLYK) has released its Annual Shareholder Letter detailing key achievements in 2024 and strategic priorities for the future. The company launched several significant initiatives including: ARI, an AI-powered healthcare guidance system for personalized medical recommendations; nationwide expansion of 24/7 telemedicine services beyond Florida; introduction of a premium concierge service with monthly subscription; and implementation of a discount prescription drug program.

The company's growth strategy focuses on scaling its platform through innovative marketing campaigns and strategic partnerships. HealthLynked plans to enhance affinity marketing by collaborating with insurance providers, major employers, and professional employer organizations (PEOs) to expand its membership base. The company's vision centers on transforming healthcare through improved care management, increased healthcare access, and leveraging patient data for medical research advancement.

HealthLynked has announced the release of ARi, an AI-driven personal healthcare assistant that aims to revolutionize patient engagement and personalized care. The patent-pending technology offers exclusive access to paid members through the HealthLynked app. Key features include personalized healthcare recommendations, effortless scheduling with voice commands, proactive health tracking, and 24/7 intelligent assistance. ARi's platform integrates seamlessly with HealthLynked's ecosystem, allowing users to manage their healthcare efficiently.

CEO Dr. Michael Dent highlighted ARi's role in providing personalized medical care, emphasizing its capabilities like voice-driven profile creation, tailored recommendations, and AI-powered diagnostic support. The technology aims to enhance diagnostic accuracy and connect patients to appropriate care, fostering a more engaged and proactive approach to healthcare.

The release is seen as a significant milestone in HealthLynked's mission to deliver smarter, patient-centered healthcare by leveraging advanced AI to empower patients with better control over their health.

HealthLynked Corp. (OTCQB: HLYK) has appointed Jeremy Daniel as its new Chief Financial Officer (CFO), effective immediately. Daniel brings over two decades of experience in financial management, strategic planning, and organizational development. His most recent position was CFO at Innoveren Scientific, where he raised over $100M in funding through public and private equity markets and led successful acquisitions.

Daniel's previous roles include CFO at Regenerative Medicine Solutions and controller at Omnicare. He is a Certified Public Accountant (CPA) with an MBA from Xavier University. In his new role, he will oversee HealthLynked's financial strategy and operations, focusing on driving growth, operational efficiency, and shareholder value.

HealthLynked Corp. (OTCQB: HLYK) has received a $500,000 payment milestone from the sale of ACO Health Partners (AHP), representing their share of AHP's ACO shared savings for the 2023 performance period. This payment completes the total cash consideration of $3 million from the January 2023 sale, which included an initial $750,000 payment, $1.75 million in participation-based payments, and the current $500,000 milestone. The sale to Palm Beach ACO was a strategic move allowing HealthLynked to focus on its core healthcare technology and patient engagement services.

HealthLynked Corp. (OTCQB: HLYK) announced Q3 2024 financial results, revealing significant changes amid strategic restructuring. Revenue declined 56% year-over-year to $0.59 million in Q3 2024, with a nine-month revenue of $2.39 million, down 50% from 2023. The company reduced practice operating expenses by 39% to $0.80 million in Q3. Operating loss increased to $1.67 million, with a net loss of $1.97 million. The company is shifting focus from clinical operations to app-based services, with telemedicine now available nationwide. CEO Dr. Michael Dent provided $2.7 million in debt funding in 2024 to support the transition.

HealthLynked Corp has announced a significant update to its Oohvie app, integrating telemedicine services and online scheduling capabilities. The enhanced platform now offers women comprehensive healthcare management through a single mobile application. The update features a redesigned home screen, improved user interface, and expanded functionalities including virtual consultations with healthcare providers. The app follows a freemium model, with basic tracking features available for free and premium services, including telemedicine access, available through a subscription at $12 monthly or $120 annually.

HealthLynked Corp. (OTCQB: HLYK) has announced a strategic partnership with 3X4 Genetics to enhance its member offerings. This collaboration aims to provide personalized genetic insights and improved healthcare services to HealthLynked members. The partnership allows members to purchase the 3X4 Blueprint for genetic testing at $299 through HealthLynked's website.

HealthLynked CEO, Michael Dent, M.D., emphasized that this partnership demonstrates their commitment to delivering cutting-edge healthcare solutions and personalized care. 3X4 Genetics CEO, Tony Hsu, highlighted the alignment between both companies in empowering patients with genetic information for optimized health and wellness.

This collaboration is part of HealthLynked's broader strategy to expand its network of strategic alliances, focusing on improving patient health through advanced diagnostics and wellness programs. The company plans to forge similar partnerships in the coming months to increase the range of services available to its members.